
Generic Drugs: Questions & Answers | FDA
Generic Drug Facts At-a-glance information on generic medicines, including why they may look different or cost less than brand-name medicines.
Generic Drug Facts | FDA
Nov 1, 2021 · Generic drugs: Get the facts. Consumer-friendly text and graphics provide a few facts about generic drug approval, quality, and performance.
First Generic Drug Approvals | FDA
Nov 25, 2024 · FDA considers first generics to be important to public health, and prioritizes review of these submissions.
FDA List of Authorized Generic Drugs
Jan 13, 2025 · The FDA List of Authorized Generics page answers what an authorized generic is and how it differs from a traditional generic. An authorized generic is used to describe an …
The Generic Drug Approval Process | FDA
Usually, as FDA approves more generics of a brand-name drug, the cost drops. Generally, multiple generic drugs for the same product create marketplace competition.
Fiscal Year 2025 Generic Drug Science and Research Initiatives …
May 22, 2025 · Topics discussed during the workshop will focus on research that is needed to address scientific knowledge gaps and associated challenges impacting the development and …
Office of Generic Drugs 2023 Annual Report | FDA
Mar 4, 2024 · Our 2023 Annual Report provides highlights of activities and accomplishments including generic drug approvals, first generic approvals, science and research innovations for …
- [PDF]
Generic Drug Facts
Generic drugs go through a rigorous review process to receive FDA approval. The FDA ensures a generic medication provides the same clinical benefit and is as safe and efective as the brand …
FDA Roundup: March 4, 2025
Mar 4, 2025 · On Monday, the FDA approved the first generics of Xarelto (rivaroxaban), 2.5 mg, tablets to reduce the risk of major cardiovascular events in adult patients with coronary artery …
FDA Approves First Generic of Once-Daily GLP-1 Injection to …
FDA approved the first generic referencing Victoza (liraglutide injection) 18 mg/3 mL, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults and ...